
P3 Health Partners Inc.: updates and filings
Price
$1.86
November 19, 2026Market cap $6.1M
What Ploutos Investor adds for P3 Health Partners
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 49% since Nov 9, 2026, when the 10-Q these figures come from was filed ($4.25 then, $2.15 on Nov 18, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 9, 2026next Feb 11, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 9, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 9, 2026Results of operationsForm8-K
- Nov 6, 2026FilingFormEFFECT
- Oct 15, 2026Shelf registration for future offeringsFormS-3
- Sep 11, 2026Material agreement entered, unregistered sale of shares, amended articles or bylawsForm8-K
- Aug 12, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 10, 2026Results of operationsForm8-K
- Jul 6, 2026Material agreement enteredForm8-K
- Jun 10, 2026Shareholder voteForm8-K
- May 26, 2026Delisting noticeForm8-K
- May 15, 2026Delisting notice, other material eventsForm8-K
- May 14, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 14, 2026Results of operationsForm8-K
- Apr 30, 2026Additional annual meeting materialFormDEFA14A
- Apr 30, 2026Annual meeting proxy statementFormDEF 14A
- Apr 28, 2026Material agreement entered, unregistered sale of shares, amended articles or bylawsForm8-K
- Apr 20, 2026Preliminary proxy statementFormPRE 14A
- Apr 3, 2026Shares registered for employeesFormS-8
- Mar 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 26, 2026Results of operationsForm8-K
- Mar 25, 2026Material agreement enteredForm8-K
- Feb 17, 2026Material agreement enteredForm8-K
- Nov 28, 2025Delisting noticeForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 9, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 9, 2026 | 8-K | Results of operations | Document |
| Nov 6, 2026 | EFFECT | Filing | Document |
| Oct 15, 2026 | S-3 | Shelf registration for future offerings | Document |
| Sep 11, 2026 | 8-K | Material agreement entered, unregistered sale of shares, amended articles or bylaws | Document |
| Aug 12, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 10, 2026 | 8-K | Results of operations | Document |
| Jul 6, 2026 | 8-K | Material agreement entered | Document |
| Jun 10, 2026 | 8-K | Shareholder vote | Document |
| May 26, 2026 | 8-K | Delisting notice | Document |
| May 15, 2026 | 8-K | Delisting notice, other material events | Document |
| May 14, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 14, 2026 | 8-K | Results of operations | Document |
| Apr 30, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 30, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 28, 2026 | 8-K | Material agreement entered, unregistered sale of shares, amended articles or bylaws | Document |
| Apr 20, 2026 | PRE 14A | Preliminary proxy statement | Document |
| Apr 3, 2026 | S-8 | Shares registered for employees | Document |
| Mar 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 26, 2026 | 8-K | Results of operations | Document |
| Mar 25, 2026 | 8-K | Material agreement entered | Document |
| Feb 17, 2026 | 8-K | Material agreement entered | Document |
| Nov 28, 2025 | 8-K | Delisting notice | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Nov 19, 2020.
The full analysis
What do P3 Health Partners's filings show?
The filings are where every one of P3 Health Partners's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.